Larotrectinib: First Global Approval

Scott, Lesley J.

doi:10.1007/s40265-018-1044-x

2019-01-11

180

PRE

Scott, Lesley J. *

DOI：10.1007/s40265-018-1044-x

原文链接

原文求助

摘要

En 中文

Larotrectinib (VITRAKVI((R))) is an orally administered, small molecule, highly-selective, tropomyosin receptor kinase (TRK) inhibitor that was developed by Loxo Oncology in collaboration with Bayer AG as a treatment for adult and paediatric patients whose cancers harbour neurotrophic receptor tyrosine kinase (NTRK) gene fusions. In November 2018 larotrectinib received its first global approval in the USA for the treatment of adult and paediatric patients with solid tumours that have a NTRK gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed following treatment. A registration application for the use of larotrectinib in paediatric and adult patients with locally advanced or metastatic solid tumours with NTRK gene fusion proteins has been submitted in the EU. This article summarizes the milestones in the development of larotrectinib leading to its first approval for the treatment of adult and paediatric patients with solid tumours that have NTRK gene fusion.

Keyword:

FUSION

期刊

Drugs

IF:

14.4

论文数:

8.4K

被引数:

2.3W

机构

springer nature

学者数:

108

论文数: 516

被引数: 0

引用论文

KETONE ESTER TREATMENT INCREASES CARDIAC KETONE UTILIZATION AND REDUCES CARDIAC INFLAMMATION IN A PORCINE MODEL OF ACUTE MYOCARDIAL INFARCTION

Journal of the American College of Cardiology

IF0

2022-03-01

OAAI

Salva Yurista; Aidan Welsh; William Jiang; Robert Eder; Shi Chen; Benjamin Bonner; Anna Foster; Jaume Coll-Font; Anthony Rosenzweig; Christopher Nguyen

TRKing Down an Old Oncogene in a New Era of Targeted Therapy

CANCER DISCOVERY

IF33.3

2015-01-11

533

OAAI

Vaishnavi, Aria; Le, Anh T.; Doebele, Robert C.

Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making

American Journal of Men's Health

IF0

2018-04-16

OAAI

Leanne Woods-Burnham; Laura Stiel; Colwick Wilson; Susanne Montgomery; Alfonso M. Durán; Herbert R. Ruckle; Rupert A. Thompson; Marino De León; Carlos A. Casiano

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children Larotrectinib在成人和儿童TRK融合阳性癌症中的疗效

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2018-02-22

1.4K

OAAI

Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; Pappo, A. S.; Turpin, B.; Dowlati, A.; Brose, M. S.; Mascarenhas, L.; Federman, N.; Berlin, J.; El-Deiry, W. S.; Baik, C.; Deeken, J.; Boni, V.; Nagasubramanian, R.; Taylor, M.; Rudzinski, E. R.; Meric-Bernstam, F.; Sohal, D. P. S.; Ma, P. C.; Raez, L. E.; Hechtman, J. F.; Benayed, R.; Ladanyi, M.; Tuch, B. B.; Ebata, K.; Cruickshank, S.; Ku, N. C.; Cox, M. C.; Hawkins, D. S.; Hong, D. S.; Hyman, D. M.

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

CANCER DISCOVERY

IF33.3

2015-09-30

376

OAAI

Doebele, Robert C.; Davis, Lara E.; Vaishnavi, Aria; Le, Anh T.; Estrada-Bernal, Adriana; Keysar, Stephen; Jimeno, Antonio; Varella-Garcia, Marileila; Aisner, Dara L.; Li, Yali; Stephens, J.; Morosini, Deborah; Tuch, Brian B.; Fernandes, Michele; Nanda, Nisha; Low, Jennifer A.

Tumor formation in Brca1 conditional mutant mice

Environmental and Molecular Mutagenesis

IF0

2002-03-29

OAAI

Chu‐Xia Deng

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy

TARGETED ONCOLOGY

IF4

2018-10-02

OAAI

Kummar, Shivaani; Lassen, Ulrik N.

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas 使用新辅助larotrectinib治疗局部晚期TRK融合肉瘤的儿童

CANCER

IF5.1

2018-09-11

112

OAAI

DuBois, Steven G.; Laetsch, Theodore W.; Federman, Noah; Turpin, Brian K.; Albert, Catherine M.; Nagasubramanian, Ramamoorthy; Anderson, Megan E.; Davis, Jessica L.; Qamoos, Hope E.; Reynolds, Mark E.; Cruickshank, Scott; Cox, Michael C.; Hawkins, Douglas S.; Mascarenhas, Leo; Pappo, Alberto S.

没有更多内容